BPS Oncology Dumps Exam Question No 4

Question No 4:

A 55 year old patient with Stage 2A HER2 positive breast cancer receiving every three week adjuvant trastuzumab therapy.  At her appointment, she complains of fatigue and the inability to do her normal daily activities. Her lab results show that she is anemic with a hemoglobin of 9.9 g/dL (hematocrit 29%).  Which of the following treatments would be best for this patient?

A. Start epoetin alfa 40,000 units SQ weekly
B. Begin darbepoetin alfa 500 mcg SQ every three weeks
C. Initiate iron sucrose 200 mg IV followed by darbepoetin 500 mcg SQ every 3 weeks
D. No erythropoiesis stimulating agent (ESA) is indicated

Answer: D

BPS Oncology Dumps Exam Question No 3

Question No 3:

The family of a 34-year-old female with advanced metastatic cervical cancer has contacted the patient's oncologist about a new experimental drug they heard about on the evening news. The drug is in clinical trials at the National Cancer Institute (NCI) and has shown promising results in the first four patients with cervical cancer who were treated. The current patient has failed all known treatment options, and because of her history of breast cancer, she is not eligible for any other clinical trials. The oncologist contacts the oncology pharmacy to inquire about the appropriate procedures for obtaining the drug. The most appropriate method is by a/an:

A. Orphan drug protocol.
B. Abbreviated new drug application.
C. Petition to the pharmaceutical manufacturer.
D. Individual patient IND.


Answer: D

BPS Oncology Dumps Exam Question No 2

Question No 2:

A51-year-old female patient has pathologic T1NOMO invasive breast cancer. Which characteristics would make this patient fit National Comprehensive Cancer Network (NCCN) guidelines for screening with a 21-gene RT-PCR assay prior to systemic adjuvant chemotherapy?

A. ER/PR negative, HER-2/neu negative
B. ER/PR negative, HER-2/neu positive
C. ER/PR positive, HER-2/neu positive
D. ER/PR positive, HER-2/neu negative

Answers: A